These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9700674)

  • 41. [Comparative study of protective effects of Cortexin, Cerebrolysin and Actovegin on memory impairment, cerebral circulation and morphological changes in the hippocampus of rats with chronic brain ischemia].
    Tyurenkov IN; Kurkin DV; Kalatanova AV; Dorotenko AR; Bakulin DA; Morkovin EI; Verholyak DV; Gorbunova YV; Atapina NV; Smirnov AV; Schmidt MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):83-89. PubMed ID: 32929929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Demonstration of therapeutic window of Cerebrolysin in embolic stroke: A prospective, randomized, blinded, and placebo-controlled study.
    Zhang L; Chopp M; Lu M; Zhang T; Li C; Winter S; Brandstaetter H; Doppler E; Meier D; Pabla P; Zhang ZG
    Int J Stroke; 2017 Aug; 12(6):628-635. PubMed ID: 28382851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of nicardipine and clonidine on cognitive functions and electroencephalography in hypertensive patients.
    Denolle T; Sassano P; Allain H; Bentué-Ferrer D; Breton S; Cimarosti I; Ouatara B; Merienne M; Gandon JM
    Fundam Clin Pharmacol; 2002 Dec; 16(6):527-35. PubMed ID: 12685512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.
    Alvarez XA; Pichel V; Pérez P; Laredo M; Corzo D; Zas R; Fernández-Novoa L; Sempere JM; Díaz J; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):585-94. PubMed ID: 11196347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical experience with Cerebrolysin.
    Molloy DW; Standish TI
    J Neural Transm Suppl; 2000; 59():293-300. PubMed ID: 10961441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacodynamics of milnacipran in young and elderly volunteers.
    Hindmarch I; Rigney U; Stanley N; Briley M
    Br J Clin Pharmacol; 2000 Feb; 49(2):118-25. PubMed ID: 10671905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
    Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
    Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The acute nootropic effects of Ginkgo biloba in healthy older human subjects: a preliminary investigation.
    Nathan PJ; Ricketts E; Wesnes K; Mrazek L; Greville W; Stough C
    Hum Psychopharmacol; 2002 Jan; 17(1):45-9. PubMed ID: 12404706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
    Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
    Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacology of DP-b99 in healthy volunteers: first administration to humans.
    Rosenberg G; Angel I; Kozak A
    Br J Clin Pharmacol; 2005 Jul; 60(1):7-16. PubMed ID: 15963088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings.
    Saletu-Zyhlarz GM; Anderer P; Wolzt M; Semlitsch HV; Assandri A; Nessi P; Nannipieri F; Rosini S; Saletu B
    Neuropsychobiology; 2009; 59(2):100-9. PubMed ID: 19365150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trophic effects of nootropic peptide preparations cerebrolysin and semax on cultured rat pheochromocytoma.
    Safarova ER; Shram SI; Grivennikov IA; Myasoedov NF
    Bull Exp Biol Med; 2002 Apr; 133(4):401-3. PubMed ID: 12124658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car.
    Ridout F; Shamsi Z; Meadows R; Johnson S; Hindmarch I
    Clin Ther; 2003 May; 25(5):1518-38. PubMed ID: 12867226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrolysin in Alzheimer's disease.
    Antón Álvarez X; Fuentes P
    Drugs Today (Barc); 2011 Jul; 47(7):487-513. PubMed ID: 22013558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective, randomized, blinded, and placebo-controlled study of Cerebrolysin dose-response effects on long-term functional outcomes in a rat model of mild traumatic brain injury.
    Zhang Y; Chopp M; Gang Zhang Z; Zhang Y; Zhang L; Lu M; Zhang T; Winter S; Brandstätter H; Mahmood A; Xiong Y
    J Neurosurg; 2018 Nov; 129(5):1295-1304. PubMed ID: 29303438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial.
    Poon W; Matula C; Vos PE; Muresanu DF; von Steinbüchel N; von Wild K; Hömberg V; Wang E; Lee TMC; Strilciuc S; Vester JC
    Neurol Sci; 2020 Feb; 41(2):281-293. PubMed ID: 31494820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Electrophysiological correlates of efficacy of nootropic drugs in the treatment of consequences of traumatic brain injury in adolescents].
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Suppl 1):27-32. PubMed ID: 20559264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
    Allain H; Tessier C; Bentué-Ferrer D; Tarral A; Le Breton S; Gandon M; Bouhours P
    Psychopharmacology (Berl); 2003 Feb; 165(4):419-29. PubMed ID: 12459926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.